Antinuclear Antibody (ANA) Test Market Anticipated To Register A CAGR Of 12.5% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.
San Francisco, 3 September 2019: The Report Antinuclear Antibody (ANA) Test Market Size, Share & Trends Analysis Report By Product, By Technique (ELISA, Immunofluorescence Assay), By Application (Rheumatoid Arthritis, SLE), By End Use, And Segment Forecasts, 2018 – 2025 The global antinuclear antibody test market size is expected to reach USD 2.36 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 12.5% over the forecast period. Rising adoption of ANA test coupled with government initiatives to treat autoimmune disorders is likely to drive the market. Furthermore, rising incidence of autoimmune disorders is projected to fuel the growth. Antinuclear Antibody (ANA) testing is an important tool to diagnose and manage autoimmune diseases such as Systemic Lupus Erythematosus (SLE) and rheumatoid arthritis. According to the Lupus Foundation of America, at least 5 million people globally and around 1.5 million people